Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1
Open accessThe DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Abstract
An assay recapitulating the 3' processing activity of HIV-1 integrase (IN) was used to screen the Boehringer Ingelheim compound collection. Hit-to-lead and lead optimization beginning with compound 1 established the importance of the C3 and C4 substituent to antiviral potency against viruses with different aa124/aa125 variants of IN. The importance of the C7 position on the serum shifted potency was established. Introduction of a quinoline substituent at the C4 position provided a balance of potency and metabolic stability. Combination of these findings ultimately led to the discovery of compound 26 (BI 224436), the first NCINI to advance into a phase Ia clinical trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although ALLINIs have yet to advance in clinical trials, several compounds display exquisite low-nM potencies to inhibit HIV-1 replication in vitro172,180,182,183.”
From Structure and function of retroviral integrase (2022) · cites this paper as [172]
In the citing paper
“Many ALLINIs were co-crystallised with the isolated HIV-1 IN CCD, and the structures revealed the molecules grip onto the LEDGF/p75 IBD binding pocket at the IN CCD dimerization interface171,172,174,175,180,186,187.”
From Structure and function of retroviral integrase (2022) · cites this paper as [172]
In the citing paper
“Lead compounds in this class were discovered using two very different high-throughput approaches: a screen for inhibitors of HIV-1 IN 3’-processing activity172, and structure-based design of small molecule inhibitors of the HIV-1 IN-LEDGF/p75 interaction171.”
From Structure and function of retroviral integrase (2022) · cites this paper as [172]
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Adverse effects of antiretroviral therapy
Carr, A., & Cooper, D. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02854-3 · Cited by 1,057
Dyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R. (1994) · Science · doi:10.1126/science.7801124 · Cited by 810
Clavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells
Maertens, G., Cherepanov, P., Pluymers, W., Busschots, K., De Clercq, E., Debyser, Z., & Engelborghs, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303594200 · Cited by 493
Christ, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., Bardiot, D., Van der Veken, N. J., Van Remoortel, B., Strelkov, S. V., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.370 · Cited by 479
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
Cherepanov, P., Ambrosio, A. L. B., Rahman, S., Ellenberger, T., & Engelman, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506924102 · Cited by 408
Jurado, K. A., Wang, H., Slaughter, A., Feng, L., Kessl, J. J., Koh, Y., Wang, W., Ballandras-Colas, A., Patel, P. A., Fuchs, J. R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300703110 · Cited by 203
Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors
Kessl, J. J., Jena, N., Koh, Y., Taskent-Sezgin, H., Slaughter, A., Feng, L., de Silva, S., Wu, L., Le Grice, S. F. J., Engelman, A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354373 · Cited by 182
Christ, F., Shaw, S., Demeulemeester, J., Desimmie, B. A., Marchand, A., Butler, S., Smets, W., Chaltin, P., Westby, M., Debyser, Z., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00717-12 · Cited by 176
Research works printed but not linked: 5
- Clavel F., 2004, N. Engl. J. Med., 350, 1023, 10.1056/nejmra025195 · doi:10.1056/nejmra025195 · Paper page
- Arribas J. R., 2013, Curr. Opin. HIV AIDS, 8, 341
- aFenwick, C.; Bethell, R.; Bonneau, P.; Duan, J.; Faucher, A.M.; Mason, S.; Poupart, M.A.; Simoneau, B.; Tsantrizos, Y.; Yoakim, C.Identification of BI-C, a novel HIV-1 non-catalytic site integrase inhibitor.18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA, 27 February–3 March, 2011 (abstract 523).
- bSimoneau, B.; Amad, M.; Bailey, M. D.; Bethell, R.; Bhardwaj, P. K.; Bilodeau, F.; Bonneau, P.; Bös, M.; Bousquet, Y.; Brochu, C.; Carson, R.; Chabot, C.; Cordingley, M.; Coulombe, R.; Duan, J.; Edwards, P.; Fader, L.; Faucher, A.M.; Fenwick, C.; Garneau, M.; Halmos, T.; Jakalian, A.; Kawai, S.; Landry, S.; Laplante, S.; Malenfant, E.; Mason, S.; Morin, S.; Parisien, M.; Pesant, M.; Poupart, M.A.; Tsantrizos, Y.; Wernic, D.; Yoakim, C.Identification of Novel Non-Catalytic Site Integrase Inhibitors (NCINIs) of LTR DNA 3′ Processing.24th International-Conference on Antiviral Research, Sofia, Bulgaria, May 8–11th, 2011, (Late Breaker abstract).
- Feng L., 2013, J. Biol. Chem., 288, 15813, 10.1074/jbc.m112.443390 · DOI · Paper page
Cited by
Items 101–199 of 199
Naidu, B. N., Patel, M., McAuliffe, B. V., Ding, B., Cianci, C., Simmermacher, J., Jenkins, S., Parker, D. D., Sivaprakasam, P., Khan, J., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02169 · Cited by 14
Lessons Learned: HIV Points the Way Towards Precision Treatment of Mixed-Lineage Leukemia
Čermáková, K., Weydert, C., Christ, F., Rijck, J. D., & Debyser, Z. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.005 · Cited by 14
Singh, P., Li, W., Bedwell, G., Fadel, H., Poeschla, E., & Engelman, A. (2022) · Viruses · doi:10.3390/v14091883 · Cited by 13
Structural Insights to Human Immunodeficiency Virus (HIV-1) Targets and Their Inhibition
Vanangamudi, M., Nair, P. C., Maida Engels, S. E., Senthilkumar, P., & Namasivayam, V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0267-2_3 · Cited by 13
Rashamuse, T. J., Fish, M. Q., Coyanis, E. M., & Bode, M. L. (2021) · Molecules · doi:10.3390/molecules26206203 · Cited by 13
Spotlight on 4‐substituted quinolines as potential anti‐infective agents: Journey beyond chloroquine
Goyal, A., Kharkwal, H., Piplani, M., Singh, Y., Murugesan, S., Aggarwal, A. K., Kumar, P., & Chander, S. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200361 · Cited by 13
Sun, L., Gao, P., Zhan, P., & Liu, X. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1210127 · Cited by 13
Discovery of novel integrase-LEDGF/p75 allosteric inhibitors based on a benzene scaffold
Sugiyama, S., Iwaki, T., Tamura, Y., Tomita, K., Matsuoka, E., Arita, S., Seki, T., Yoshinaga, T., & Kawasuji, T. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115643 · Cited by 13
Virus–Host Interactions in Retrovirus Integration
Engelman, A. N., & Maertens, G. N. (2018) · Retrovirus-Cell Interactions · doi:10.1016/b978-0-12-811185-7.00004-2 · Cited by 12
A mini-review on integrase inhibitors: The cornerstone of next-generation HIV treatment
Shalbi, F., & Ali, A. R. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116900 · Cited by 12
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor
Parcella, K. E., Wang, T., Eastman, K. J., Zhang, Z., Yin, Z., Patel, M., Tu, Y., Zheng, B. Z., Walker, M. A., Saulnier, M. G., et al. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00115 · Cited by 12
Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors
Sun, J., & Kessl, J. J. (2024) · Viruses · doi:10.3390/v16020200 · Cited by 12
Ni, Z., Zhuang, J., Gao, Y.-D., Gao, G., Liu, Z., Su, P., Cheng, G., & Yang, L. (2025) · Advanced Science · doi:10.1002/advs.202510455 · Cited by 11
Cui, D., Zhang, B. W., Tan, Z., & Levy, R. M. (2019) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.9b00740 · Cited by 11
Influence of the amino-terminal sequence on the structure and function of HIV integrase
Eilers, G., Gupta, K., Allen, A., Zhou, J. O., Hwang, Y., Cory, M., Bushman, F. D., & Duyne, G. D. V. (2020) · Retrovirology · doi:10.1186/s12977-020-00537-x · Cited by 11
Eilers, G., Gupta, K., Allen, A., Montermoso, S., Murali, H., Sharp, R. B., Hwang, Y., Bushman, F. D., & Duyne, G. D. V. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011097 · Cited by 11
Agharbaoui, F. E., Hoyte, A. C., Ferro, S., Gitto, R., Buemi, M. R., Fuchs, J. R., Kvaratskhelia, M., & Luca, L. D. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.07.077 · Cited by 11
Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors
Dinh, L. P., Sun, J., Glenn, C. D., Patel, K., Pigza, J. A., Donahue, M. G., Yet, L., & Kessl, J. J. (2022) · Viruses · doi:10.3390/v14071466 · Cited by 10
Carmona, J. A., Rodríguez‐Salamanca, P., Fernández, R., Lassaletta, J. M., & Hornillos, V. (2023) · Angewandte Chemie · doi:10.1002/ange.202306981 · Cited by 10
Trends in Basic and Therapeutic Options in HIV Infection - Towards a Functional Cure
Ibeh, B. O. (2015) · InTech eBooks · doi:10.5772/58666 · Cited by 9
Methods for the Analyses of Inhibitor-Induced Aberrant Multimerization of HIV-1 Integrase
Kessl, J. J., Sharma, A., & Kvaratskhelia, M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3046-3_10 · Cited by 9
Atroposelective N-Allylic Alkylation Enables Construction of Axially Chiral Arylimidazoles
Wang, Y., Chen, K., Zhou, H., Chen, X., & Xu, J. (2025) · Organic Letters · doi:10.1021/acs.orglett.5c01977 · Cited by 8
Brief Histories of Retroviral Integration Research and Associated International Conferences
Grandgenett, D. P., & Engelman, A. (2024) · Viruses · doi:10.3390/v16040604 · Cited by 8
Dawei, Z., He, H.-Q., Mengmeng, L., Meng, Z., & Shunxing, G. (2016) · Scientific Reports · doi:10.1038/srep33477 · Cited by 8
Identification and Optimization of a Novel HIV-1 Integrase Inhibitor
Adu‐Ampratwum, D., Pan, Y., Koneru, P. C., Antwi, J., Hoyte, A. C., Kessl, J. J., Griffin, P. R., Kvaratskhelia, M., Fuchs, J. R., & Larue, R. C. (2022) · ACS Omega · doi:10.1021/acsomega.1c06378 · Cited by 8
Parcella, K. E., Patel, M., Tu, Y., Eastman, K. J., Peese, K. M., Gillis, E. P., Belema, M., Dicker, I. B., McAuliffe, B. V., Ding, B., et al. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116833 · Cited by 8
Li, W., Huang, S., Liu, Q., Li, X., & Chen, W. (2023) · Organic Chemistry Frontiers · doi:10.1039/d3qo01208e · Cited by 8
Cyclic Hexapeptide Mimics of the LEDGF Integrase Recognition Loop in Complex with HIV‐1 Integrase
Northfield, S. E., Wielens, J., Headey, S. J., Williams‐Noonan, B. J., Mulcair, M. D., Scanlon, M. J., Parker, M. W., Thompson, P. E., & Chalmers, D. K. (2018) · ChemMedChem · doi:10.1002/cmdc.201800129 · Cited by 8
Musat, M., Nițulescu, G. M., Surleac, M. D., Tsatsakis, A. M., Spandidos, D. A., & Margina, D. M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10777 · Cited by 8
Dzedulionytė, K., Žukauskaitė, A., Šačkus, A., & Arbačiauskienė, E. (2025) · The Chemical Record · doi:10.1002/tcr.202500024 · Cited by 7
Application in Drugs and Materials
Wang, Y., Xiang, S., & Tan, B. (2021) · Wiley eBooks · doi:10.1002/9783527825172.ch11 · Cited by 7
New designs for HIV-1 integrase inhibitors: a patent review (2018-present)
Taoda, Y., Sugiyama, S., & Seki, T. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2178300 · Cited by 7
Enantioselective Synthesis of Benzodihydrofurans Bearing Axial and Central Stereogenic Elements
Domain, A., Bao, X., Rodriguez, J., & Bonne, D. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202403374 · Cited by 7
Sun, Q., Vijayan, R. S. K., Levy, R. M., & Deng, N. (2020) · Protein Science · doi:10.1002/pro.4004 · Cited by 7
Roberts, R. A., Campbell, R. A., Sikakana, P., Sadler, C., Osier, M. R., Xu, Y., Feng, J. Y., Mitchell, M. L., Sakowicz, R., Chester, A. E., et al. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab073 · Cited by 6
Parmar, K. S., Bawel, S. A., Popescu, M. V., Mai, B. K., Timmerman, J. C., Altundas, B., Paton, R. S., & Denmark, S. E. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c10238 · Cited by 6
New Antiretrovirals for HIV and Antivirals for HBV
Lazerwith, S. E., Siegel, D. S., McFadden, R. M., Mish, M., & Tse, W. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12407-2 · Cited by 6
Study on suitable analysis method for HIV-1 non-catalytic integrase inhibitor
Park, K. H., Kim, M., Bae, S. E., Lee, H. J., Kim, K.-C., Choi, B. S., & Kim, Y. B. (2021) · Virology Journal · doi:10.1186/s12985-020-01476-x · Cited by 6
Free Energy-Based Computational Methods for the Study of Protein-Peptide Binding Equilibria
Gallicchio, E. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1855-4_15 · Cited by 6
Recent advancements in carbonylative synthesis of quinolinones
Novello, M., Mancuso, R., Gabriele, B., & Wu, X. (2026) · Chemical Communications · doi:10.1039/d6cc00428h · Cited by 5
Adachi, K., Manabe, T., Yamasaki, T., Suma, A., Orita, T., Furuzono, T., Adachi, T., Ohata, Y., Akiyama, Y., & Miyazaki, S. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129864 · Cited by 5
Expeditious Synthesis of a Potent Allosteric HIV-1 Integrase Inhibitor GSK3839919A
Bobko, M. A., Elward, J. M., Naidu, B. N., Nieves‐Quinones, Y., Reiher, C. A., Su, Q., Sun, L. D., Woodard, J., Xie, S., Yang, W., et al. (2023) · Organic Process Research & Development · doi:10.1021/acs.oprd.2c00343 · Cited by 5
Enantioselective cycloaddition desymmetrization en route to multi-stereogenic atropisomers
Hu, T.-Y., Meng, H.-J., Ma, B., Deng, T., Chen, J., & Zhou, L. P. (2026) · Organic Chemistry Frontiers · doi:10.1039/d6qo00202a · Cited by 4
Authentic HIV-1 integrase inhibitors for the treatment of HIV-1/AIDS
Liao, C., & Wang, Q. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18611-0.00026-7 · Cited by 4
Wang, H. Z., Peng, X.-Q., Yang, Y., Geng, Z., Sun, B.-L., Zhou, L. P., & Chen, J. (2024) · Organic Letters · doi:10.1021/acs.orglett.4c03827 · Cited by 4
NMR spectroscopy can help accelerate antiviral drug discovery programs
LaPlante, S. R., Coric, P., Bouaziz, S., & França, T. C. C. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2024.105297 · Cited by 4
Self-citationHIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence
Zhao, X. Z., Métifiot, M., Kiselev, E., Kessl, J. J., Maddali, K., Marchand, C., Kvaratskhelia, M., Pommier, Y. G., & Burke, T. R. (2018) · Molecules · doi:10.3390/molecules23081858 · Cited by 4
Taoda, Y., Akiyama, T., Tomita, K., Fujiwara-Kitamura, M., Tamura, Y., Kawasuji, T., Matsuoka, E., Akihisa, E., Seki, T., & Yoshinaga, T. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128664 · Cited by 4
Chen, B., Wang, Z., Dandan, H., Yang, F., Liu, Y., Shao, Y., Ma, X., & Cheng, D. (2025) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.70150 · Cited by 3
Bourquin, R. A., Sorenson, A. E., & Schaeffer, P. M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142859 · Cited by 3
The Impact of Modern Antiretroviral Therapy on Lipid Metabolism of HIV-1 Infected Patients
da Cunha, J., Maselli, L. M. F., Bydlowski, S. P., & Spada, C. (2015) · InTech eBooks · doi:10.5772/61061 · Cited by 3
Ciubotaru, M., Musat, M. G., Surleac, M. D., Ionita, E., Petrescu, A., Abele, E., & Abele, R. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180406114405 · Cited by 3
Gordon, C. P., Dalton, N., Vandegraaff, N., Deadman, J. J., Rhodes, D. I., Coates, J. A. V., Pyne, S. G., Griffith, R., Bremner, J. B., & Keller, P. A. (2017) · Tetrahedron · doi:10.1016/j.tet.2017.11.052 · Cited by 2
High-performance hairpin-whiptail DNA target for HIV-1 integrase assay
Bourquin, R. A., Sorenson, A. E., & Schaeffer, P. M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145195 · Cited by 1
Liao, C., Zhao, X. Z., & Wang, Q. (2025) · Medicinal Research Reviews · doi:10.1002/med.70023 · Cited by 1
Ramiizah, R., Sururi, A. M., Sutriyansyah, R. A., Ramadhani, D., Tsana, A. H., Kristyandari, H., Tukiran, T., Rahayu, D. A., & MAMAT, N. B. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i11.15 · Cited by 1
Adachi, K., Manabe, T., Yamasaki, T., Suma, A., Ogoshi, Y., Takahashi, A., Orita, T., Nomura, A., Adachi, T., Ohata, Y., et al. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118526 · Cited by 1
Targeting HIV-1 integrase: A review of options, challenges and future directions
Bourquin, R. A., & Schaeffer, P. M. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.153092 · Cited by 1
Saccoliti, F., Patacchini, E., Cara, E., Zarbo, L., Messore, A., Albano, A., Ruggieri, G., Madia, V. N., Scipione, L., Costi, R., et al. (2026) · ChemMedChem · doi:10.1002/cmdc.70428 · Cited by 1
Nakamura, T., Campbell, J. R., Moore, A. R., Otsu, S., Aikawa, H., Tamamura, H., & Mitsuya, H. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.07.023 · Cited by 1
Cabotegravir (Vocabria): An HIV Integrase Strand Transfer Inhibitor for Treating HIV Infection
Li, J. J. (2024) · Wiley eBooks · doi:10.1002/9781394225156.ch3 · Cited by 1
Synthetic and Theoretical Studies for Cyclization Reactions to Form C-C and C-N Bonds
Jentsch, N. G. (2018) · Aquila Digital Community (University of Southern Mississippi) · Cited by 1
Barman, T. K., Hazarika, A. K., Kalita, U., Dhar, R., Borah, L., Chetri, S., & Ghosh, S. S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4129265 · Cited by 1
Tencer, A. (2016) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/h3dy-2937 · Cited by 1
Hiv Integrase Mechanisms Of Resistance To Raltegravir, Elvitegravir, And Dolutegravir
Ross, K. T. (2015) · Human Biology
Mechanism of action of allosteric HIV-1 integrase inhibitors
Slaughter, A. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
THE DESIGN, SYNTHESIS AND OPTIMIZATION OF ALLOSTERIC HIV-1 INTEGRASE INHIBITORS
Antwi, J. (2017) · OhioLink ETD Center (Ohio Library and Information Network)
Kalathiya, U., Padariya, M., & Bagiński, M. (2018) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1646
Approaches Towards the Inhibition of Anti-Apoptotic Proteins
Iegre, J. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.39376
The Use of Heterocycles as Important Structures in Medicinal Chemistry
Weast, S. (2019) · Aquila Digital Community (University of Southern Mississippi)
Free Energy Methods to Assist Drug Discovery: Studies of Affinity, Permeability and Dynamics
Williams‐Noonan, B. J. (2020) · Figshare · doi:10.26180/11889123
Intermolecular Palladium-Catalyzed Atropo-Enantioselective C–H Arylation of Heteroarenes
Lautens, M., & Marchese, A. D. (2020) · Synfacts · doi:10.1055/s-0040-1707637
Research progress in small-molecule modulators of protein-protein interactions
Yang, B., & Qi, X. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0034
Dash, S., Kini, S. G., & Sharma, A. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2539203
Li, W., Qi, Z., An, Z., Wei, Y., Lin, B., Chen, W., & Liu, Y. (2025) · Tetrahedron · doi:10.1016/j.tet.2025.135069
Tocco, G., Laus, A., Casula, M., Caboni, P., Beutler, J. A., Tramontano, E., & Esposito, F. (2025) · Molecules · doi:10.3390/molecules30244709
Development of a high-throughput HIV-1 integrase drug screening platform
Bourquin, R. A. (2023) · ResearchOnline at James Cook University (James Cook University) · doi:10.25903/qrbs-0s56
HIV nucleaire import en chromatine lezing als nieuwe doelwitten voor geneesmiddelenontwikkeling
Blokken, J. (2018) · Lirias
Structural And Biochemical Studies Of Hiv-1 Integration And Inhibition
Eilers, G. (2001) · Scholarly Commons (University of Pennsylvania)
新規 HIV-1 integrase-LEDGF/p75 allosteric inhibitors の探索合成研究
Sugiyama, S. (2021) · Institutional Repositories DataBase (IRDB) · doi:10.15083/0002008288
医薬有用分子の効率的創出を志向した 新規 Friedel-Crafts 型反応の開発
鈴木, 雄. (2016) · Institutional Repositories DataBase (IRDB)
Développement d'outils pour l'étude des interactions protéine-protéine
Milhas, S. (2016) · theses.fr (ABES) · doi:10.70675/7dcf6f45z231cz483fzb8f5z5cd27c8b0499
Caractérisation des voies d’échappement aux inhibiteurs d’intégrase du VIH-1
Thierry, E. (2015) · theses.fr (ABES) · doi:10.70675/602eaec1z5d9az4bb2za08dz10755e91efc2
HIV-1 Integrase During the Time: History of Drugs and Effort for the New Inhibitors’ Identification
Esposito, F., Saccoliti, F., Patacchini, E., & Santo, R. D. (2026) · Topics in medicinal chemistry · doi:10.1007/7355_2026_180
Protein‐Protein Interaction as an Efficient Target to Inhibit HIV‐1 Integrase
Zarghi, A., & Hajimahdi, Z. (2026) · Archiv der Pharmazie · doi:10.1002/ardp.70221
Wang, Z.-Y., Lu, C., & Lu, C. (2026) · Organic Chemistry Frontiers · doi:10.1039/d6qo00787b
BindingDB (2020) · UC San Diego · doi:10.7270/q2pc352q
BindingDB (2026) · UC San Diego · doi:10.7270/q2pg1xnq
BindingDB Entry 50010092: Indole-based allosteric inhibitors of HIV-1 integrase.
BindingDB (2021) · UC San Diego · doi:10.7270/q2r214vc
BindingDB Entry 50009955: Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs.
BindingDB (2021) · UC San Diego · doi:10.7270/q2ks6w19
Highly tunable artificial Suzukiase catalyzes the atroposelective synthesis of N -heterobiarylsPreprint
See, W. W. L., Gorbachev, V. M., Dolder, P., Qi, N., Prescimone, A., & Ward, T. R. (2026) · ChemRxiv · doi:10.26434/chemrxiv.15011547/v1
Metadata
- Authors
- Fader, L. D., Malenfant, E., Parisien, M., Carson, R., Bilodeau, F., Landry, S., Pesant, M., Brochu, C., Morin, S., Chabot, C., Halmos, T., Bousquet, Y., Bailey, M. D., Kawai, S. H., Coulombe, R., LaPlante, S., Jakalian, A., Bhardwaj, P. K., Wernic, D., Schroeder, P., Amad, M., Edwards, P., Garneau, M., Duan, J., Cordingley, M., Bethell, R., Mason, S. W., Bös, M., Bonneau, P., Poupart, M.-A., Faucher, A.-M., Simoneau, B., Fenwick, C., Yoakim, C., & Tsantrizos, Y.
- Affiliations
- Boehringer Ingelheim (Canada) (CA)
- Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Québec H7S 2G5, Canada
- Corresponding author
- Fader, Lee D.
- ORCID
- Venue
- ACS Medicinal Chemistry Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-01-28
- Volume
- 5
- Issue
- 4
- Pages
- 422-427
- ISSN
- 1948-5875 (ISSN-L)
- PMC
- PMC4027581
- OpenAlex
- W2000546717
- Cited by
- 178
- References
- 23
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 13 · 2023: 15 · 2022: 12 · 2021: 15 · 2020: 19 · 2019: 17 · 2018: 12 · 2017: 10 · 2016: 20 · 2015: 11 · 2014: 9
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- ACS Medicinal Chemistry Letters (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- HIV-1 integrase, antiviral drug discovery, hit-to-lead optimization, metabolic stability, lead optimization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.